Bioray Biotech Co., Ltd (TPEX:7561)

Taiwan · Delayed Price · Currency is TWD

18.65

+0.15 (0.81%)

Jul 30, 2026, 1:33 PM CST

Bioray Biotech Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	222.73	222.73	201.71	191.83	190.6	148.02
Revenue Growth	-3.19%	10.42%	5.15%	0.65%	28.77%	-5.30%
Gross Profit	105.94	105.94	79.03	77.65	80.51	67.29
Operating Income	37.9	37.9	-4.32	-19.33	-0.31	-8.11
Net Income	32.25	32.25	1	-11.56	0.5	-7.19
Earnings Per Share	1.09	1.09	0.03	-0.38	0.02	-0.27
EPS Growth	6.29%	3533.33%	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	204.92	204.92	178.21	97.02	139.07	126.31
Total Debt	46.29	46.29	85.78	69.79	100.91	53.43
Net Cash (Debt)	158.63	158.63	92.43	27.23	38.16	72.88
Net Cash Growth	53.18%	71.62%	239.42%	-28.63%	-47.65%	-13.57%
Net Cash Per Share	5.36	5.36	3.10	0.91	1.36	2.72

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	71.64	71.64	16.65	-0.76	2.48	8.83
Capital Expenditures	-0.37	-0.37	-3.22	-10.02	-59.64	-14.98
Free Cash Flow	71.27	71.27	13.43	-10.78	-57.16	-6.15
Free Cash Flow Growth	127.99%	430.67%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	47.56%	47.56%	39.18%	40.48%	42.24%	45.46%
Operating Margin	17.02%	17.02%	-2.14%	-10.08%	-0.16%	-5.48%
Pretax Margin	18.52%	18.52%	0.68%	-7.40%	0.36%	-4.17%
Profit Margin	14.48%	14.48%	0.50%	-6.03%	0.26%	-4.86%
FCF Margin	32.00%	32.00%	6.66%	-5.62%	-29.99%	-4.15%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.950	0.950	-	-	0.200
Dividend Per Share Growth	0%	-	-	-	-
Dividend Yield	4.88%	4.54%	-	-	0.67%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.97	19.17	634.18	-	1802.11	-
P/FCF Ratio	7.68	8.68	47.32	-	-	-
PS Ratio	2.46	2.78	3.15	4.85	4.73	8.72